Manager, Financial Planning & Analysis at CooperCompanies
Trumbull, Connecticut, United States -
Full Time


Start Date

Immediate

Expiry Date

17 Jun, 26

Salary

0.0

Posted On

19 Mar, 26

Experience

5 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

No

Skills

Financial Consolidation Systems, HFM, Adaptive Planning, Manufacturing Cost Structures, Operational Drivers, Cost Flow Analysis, Financial Planning, Forecasting, Variance Analysis, Capital Expenditure (CapEx), Standard Cost Process, Microsoft Excel, PowerPoint, Teams, US GAAP, SOX

Industry

Medical Equipment Manufacturing

Description
  This role is a key position within the Life Science Operations & Innovation FP&A organization, responsible for all aspects of consolidated Cost of Goods Sold (COGS) reporting across the Genomics, Stem Cell, Gamete businesses, and QA Life Sciences. The role reports directly to the Director of Life Science Operations & Innovation and collaborates closely with the Global FP&A team, the corporate accounting organization, and cross functional business partners throughout the company.   The FP&A Manager, Life Science Operations helps lead the monthly and quarterly financial planning and forecasting processes for Life Science Operations. This role oversees the full planning lifecycle, including establishing calendars and milestones, developing and maintaining master templates, and delivering timely, high‑quality variance analysis and financial commentary for the annual operating plan, recurring forecasts, and actual results.  Beyond core FP&A responsibilities, this position provides essential support for the Life Science Capital Expenditure (CapEx) process and lead the standard cost process for Stem Cell and Genomics.    Success in this role requires strong proficiency in financial consolidation systems (e.g., HFM, Adaptive, or comparable tools) and a solid understanding of manufacturing cost structures, operational drivers, and how cost flows operate within a production environment.
Responsibilities
This role is responsible for consolidated Cost of Goods Sold (COGS) reporting across Genomics, Stem Cell, and Gamete businesses, leading monthly and quarterly financial planning and forecasting processes for Life Science Operations. The manager also supports the Capital Expenditure process and leads the standard cost process for specific business units.
Loading...